Seven Virginia hemp businesses filed suit July 31 in the U.S. District Court for the Western District of Virginia, seeking to block a budget provision that eliminates a longstanding exception allowing consumable hemp products to exceed 2 milligrams of total THC per package when CBD content is at least 25 times higher. Without that carve-out, products sold across the commonwealth must fall under both the 2-mg cap and the federal 0.3 percent total THC concentration threshold. The plaintiffs say the rule, set to take effect August 15, gives them roughly 40 days to reformulate products, renegotiate manufacturing contracts and dispose of inventory that will suddenly be unsellable.
The compressed timeline is the real story here. Hemp retailers operate on thin margins and long lead times - packaging runs, third-party lab testing, COA verification, wholesale purchase orders - and none of that machinery turns on a dime. Operators in neighboring states have faced similar whiplash as intoxicating hemp products drew regulatory scrutiny, and the compliance burden tends to fall hardest on smaller, single-state retailers without the balance sheet to absorb a sudden inventory write-off. It's the kind of disruption that pushes operators to reassess every part of the back office, from supplier contracts to the systems tracking sales at the register; retailers watching Virginia's fight closely may recognize why so many multistate operators lean on dedicated retail infrastructure, including POS software for Tennessee cannabis retailers, to manage compliance shifts without losing visibility into inventory or sales data. POS software for Tennessee cannabis retailers
What the Lawsuit Actually Argues
The complaint doesn't challenge Virginia's authority to regulate hemp. It challenges how the state is doing it - abruptly, without a transition period, and without compensation for inventory that becomes unsellable overnight. The plaintiffs frame this as an unconstitutional taking, paired with due process and equal protection claims, because businesses built loans, leases and staffing plans around a regulatory structure the state itself established in 2023. That framework, sponsored by then-state Sen. Emmett Hanger, set the 2-mg limit alongside the 25-to-1 exception while also mandating child-resistant packaging, independent lab testing, warning labels and a minimum purchase age of 21 - hardly an unregulated market, the plaintiffs argue, even if state officials now describe it as a loophole.
The Compliance Gap Regulators Are Trying to Close
Virginia officials counter that intoxicating hemp products have spread into convenience stores and vape shops operating outside the oversight structure built for licensed marijuana dispensaries. That's a real regulatory gap, and not unique to Virginia - it's the same tension playing out in California's stricter emergency rules, Minnesota's serving-size-based framework, and Texas's outright prohibition on delta-8 and other THC isomers. The commonwealth's approach ties the restriction to total package THC rather than concentration per serving, which plaintiffs argue ignores how intoxicating a product actually is. Whether a judge finds that distinction constitutionally significant is now the central question in the case.
A Transition Problem, Not Just a Policy One
Even critics who support tighter hemp rules, including Marijuana Justice's Chelsea Higgs Wise, have flagged the lack of a clear off-ramp for businesses holding inventory that will no longer qualify for sale after August 15 - particularly with Virginia's regulated adult-use marijuana market not launching until July 2027. That eleven-month gap leaves a regulatory void: no legal outlet for higher-THC hemp products, no compensation mechanism, and limited guidance for retailers on what to do with stock sitting in the back room. For an industry already navigating shifting federal hemp definitions taking effect in November, Virginia's case is becoming a test of how much disruption regulators can impose on licensed, tax-paying retailers before due process concerns catch up with public health goals.